Analyst Reco. Qiagen N.V. Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 10:20:47 2024-07-05 am EDT			5-day change	1st Jan Change
37.76 ^EUR	-0.32%		-2.29%	-6.81%

Jun. 27	Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50	MT
Jun. 21	Qiagen Seeks M&A	CI

Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50	Jun. 27	MT
Invest Securities Raises Qiagen PT, Maintains Neutral Rating	Jun. 19	MT
UBS Raises Qiagen Price Target to $46 From $44, Maintains Neutral Rating	Jun. 18	MT
JPMorgan Raises Price Target on Qiagen to $54 From $52, Maintains Overweight Rating	Jun. 18	MT
QIAGEN NV : Gets a Neutral rating from UBS	Jun. 18	ZD
QIAGEN NV : Deutsche Bank reaffirms its Buy rating	Jun. 18	ZD
QIAGEN NV : Berenberg remains its Buy rating	Jun. 18	ZD
QIAGEN NV : Berenberg maintains a Buy rating	May. 21	ZD
QIAGEN NV : Berenberg reaffirms its Buy rating	Apr. 30	ZD
QIAGEN : A decent start to 2024; guidance unchanged	Apr. 30
QIAGEN NV : Deutsche Bank reiterates its Buy rating	Apr. 30	ZD
QIAGEN NV : Jefferies remains Neutral	Apr. 30	ZD
QIAGEN NV : UBS remains Neutral	Apr. 30	ZD
QIAGEN NV : UBS remains Neutral	Apr. 30	ZD
QIAGEN NV : UBS sticks Neutral	Apr. 30	ZD
QIAGEN NV : Deutsche Bank reiterates its Buy rating	Apr. 16	ZD
QIAGEN NV : UBS reaffirms its Neutral rating	Mar. 01	ZD
Morgan Stanley Upgrades Qiagen to Overweight From Equalweight, Adjusts Price Target to $49.48 From $51	Feb. 16	MT
QIAGEN NV : Berenberg reiterates its Buy rating	Feb. 16	ZD
QIAGEN NV : Deutsche Bank remains its Buy rating	Feb. 14	ZD

No results for this search

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 09:32 am EDT